ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CD30 (TNFRSF8) Protein Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-6P12633
Home | Market Reports | Health| Pharmacy
Global CD30 TNFRSF8 Protein Market Research Report 2022
BUY CHAPTERS

Global CD30 (TNFRSF8) Protein Market Research Report 2024

Code: QYRE-Auto-6P12633
Report
April 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bio-Techne
Elabscience Biotechnology Inc.
Abbexa
MyBioSource
ProSpec-Tany TechnoGene Ltd
KACTUS
G&P Biosciences
ACROBiosystems
Assay Genie
ZellBio GmbH
Sino Biological Inc
OriGene Technologies, Inc.

CD30 (TNFRSF8) Protein Market

CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication.
The global CD30 (TNFRSF8) Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CD30 (TNFRSF8) Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CD30 (TNFRSF8) Protein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of CD30 (TNFRSF8) Protein include Sino Biological, Inc., Bio-Techne, Elabscience Biotechnology Inc., Abbexa, MyBiosource, Inc., OriGene Technologies, Inc., Prospec-Tany Technogene Ltd., KACTUS and G&P Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD30 (TNFRSF8) Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD30 (TNFRSF8) Protein.

Report Scope

The CD30 (TNFRSF8) Protein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CD30 (TNFRSF8) Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD30 (TNFRSF8) Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CD30 (TNFRSF8) Protein Market Report

Report Metric Details
Report Name CD30 (TNFRSF8) Protein Market
Segment by Type
  • Purity : Greater Than 85%
  • Purity : Greater Than 90%
  • Purity : Greater Than 95%
  • Purity : Greater Than 97%
  • Others
Segment by Application
  • SDS-PAGE
  • ELISA
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, Inc., Bio-Techne, Elabscience Biotechnology Inc., Abbexa, MyBiosource, Inc., OriGene Technologies, Inc., Prospec-Tany Technogene Ltd., KACTUS, G&P Biosciences, ACROBiosystems, Assay Genie, ZellBio GmbH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of CD30 (TNFRSF8) Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of CD30 (TNFRSF8) Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CD30 (TNFRSF8) Protein Market report?

Ans: The main players in the CD30 (TNFRSF8) Protein Market are Sino Biological, Inc., Bio-Techne, Elabscience Biotechnology Inc., Abbexa, MyBiosource, Inc., OriGene Technologies, Inc., Prospec-Tany Technogene Ltd., KACTUS, G&P Biosciences, ACROBiosystems, Assay Genie, ZellBio GmbH

What are the Application segmentation covered in the CD30 (TNFRSF8) Protein Market report?

Ans: The Applications covered in the CD30 (TNFRSF8) Protein Market report are SDS-PAGE, ELISA, Others

What are the Type segmentation covered in the CD30 (TNFRSF8) Protein Market report?

Ans: The Types covered in the CD30 (TNFRSF8) Protein Market report are Purity : Greater Than 85%, Purity : Greater Than 90%, Purity : Greater Than 95%, Purity : Greater Than 97%, Others

1 CD30 (TNFRSF8) Protein Market Overview
1.1 Product Overview and Scope of CD30 (TNFRSF8) Protein
1.2 CD30 (TNFRSF8) Protein Segment by Type
1.2.1 Global CD30 (TNFRSF8) Protein Market Value Comparison by Type (2024-2030)
1.2.2 Purity : Greater Than 85%
1.2.3 Purity : Greater Than 90%
1.2.4 Purity : Greater Than 95%
1.2.5 Purity : Greater Than 97%
1.2.6 Others
1.3 CD30 (TNFRSF8) Protein Segment by Application
1.3.1 Global CD30 (TNFRSF8) Protein Market Value by Application: (2024-2030)
1.3.2 SDS-PAGE
1.3.3 ELISA
1.3.4 Others
1.4 Global CD30 (TNFRSF8) Protein Market Size Estimates and Forecasts
1.4.1 Global CD30 (TNFRSF8) Protein Revenue 2019-2030
1.4.2 Global CD30 (TNFRSF8) Protein Sales 2019-2030
1.4.3 Global CD30 (TNFRSF8) Protein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 CD30 (TNFRSF8) Protein Market Competition by Manufacturers
2.1 Global CD30 (TNFRSF8) Protein Sales Market Share by Manufacturers (2019-2024)
2.2 Global CD30 (TNFRSF8) Protein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global CD30 (TNFRSF8) Protein Average Price by Manufacturers (2019-2024)
2.4 Global CD30 (TNFRSF8) Protein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD30 (TNFRSF8) Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD30 (TNFRSF8) Protein, Product Type & Application
2.7 CD30 (TNFRSF8) Protein Market Competitive Situation and Trends
2.7.1 CD30 (TNFRSF8) Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD30 (TNFRSF8) Protein Players Market Share by Revenue
2.7.3 Global CD30 (TNFRSF8) Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD30 (TNFRSF8) Protein Retrospective Market Scenario by Region
3.1 Global CD30 (TNFRSF8) Protein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global CD30 (TNFRSF8) Protein Global CD30 (TNFRSF8) Protein Sales by Region: 2019-2030
3.2.1 Global CD30 (TNFRSF8) Protein Sales by Region: 2019-2024
3.2.2 Global CD30 (TNFRSF8) Protein Sales by Region: 2025-2030
3.3 Global CD30 (TNFRSF8) Protein Global CD30 (TNFRSF8) Protein Revenue by Region: 2019-2030
3.3.1 Global CD30 (TNFRSF8) Protein Revenue by Region: 2019-2024
3.3.2 Global CD30 (TNFRSF8) Protein Revenue by Region: 2025-2030
3.4 North America CD30 (TNFRSF8) Protein Market Facts & Figures by Country
3.4.1 North America CD30 (TNFRSF8) Protein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America CD30 (TNFRSF8) Protein Sales by Country (2019-2030)
3.4.3 North America CD30 (TNFRSF8) Protein Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD30 (TNFRSF8) Protein Market Facts & Figures by Country
3.5.1 Europe CD30 (TNFRSF8) Protein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe CD30 (TNFRSF8) Protein Sales by Country (2019-2030)
3.5.3 Europe CD30 (TNFRSF8) Protein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD30 (TNFRSF8) Protein Market Facts & Figures by Country
3.6.1 Asia Pacific CD30 (TNFRSF8) Protein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific CD30 (TNFRSF8) Protein Sales by Country (2019-2030)
3.6.3 Asia Pacific CD30 (TNFRSF8) Protein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD30 (TNFRSF8) Protein Market Facts & Figures by Country
3.7.1 Latin America CD30 (TNFRSF8) Protein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America CD30 (TNFRSF8) Protein Sales by Country (2019-2030)
3.7.3 Latin America CD30 (TNFRSF8) Protein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD30 (TNFRSF8) Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa CD30 (TNFRSF8) Protein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa CD30 (TNFRSF8) Protein Sales by Country (2019-2030)
3.8.3 Middle East and Africa CD30 (TNFRSF8) Protein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD30 (TNFRSF8) Protein Sales by Type (2019-2030)
4.1.1 Global CD30 (TNFRSF8) Protein Sales by Type (2019-2024)
4.1.2 Global CD30 (TNFRSF8) Protein Sales by Type (2025-2030)
4.1.3 Global CD30 (TNFRSF8) Protein Sales Market Share by Type (2019-2030)
4.2 Global CD30 (TNFRSF8) Protein Revenue by Type (2019-2030)
4.2.1 Global CD30 (TNFRSF8) Protein Revenue by Type (2019-2024)
4.2.2 Global CD30 (TNFRSF8) Protein Revenue by Type (2025-2030)
4.2.3 Global CD30 (TNFRSF8) Protein Revenue Market Share by Type (2019-2030)
4.3 Global CD30 (TNFRSF8) Protein Price by Type (2019-2030)
5 Segment by Application
5.1 Global CD30 (TNFRSF8) Protein Sales by Application (2019-2030)
5.1.1 Global CD30 (TNFRSF8) Protein Sales by Application (2019-2024)
5.1.2 Global CD30 (TNFRSF8) Protein Sales by Application (2025-2030)
5.1.3 Global CD30 (TNFRSF8) Protein Sales Market Share by Application (2019-2030)
5.2 Global CD30 (TNFRSF8) Protein Revenue by Application (2019-2030)
5.2.1 Global CD30 (TNFRSF8) Protein Revenue by Application (2019-2024)
5.2.2 Global CD30 (TNFRSF8) Protein Revenue by Application (2025-2030)
5.2.3 Global CD30 (TNFRSF8) Protein Revenue Market Share by Application (2019-2030)
5.3 Global CD30 (TNFRSF8) Protein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sino Biological, Inc. CD30 (TNFRSF8) Protein Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Corporation Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bio-Techne CD30 (TNFRSF8) Protein Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Elabscience Biotechnology Inc.
6.3.1 Elabscience Biotechnology Inc. Corporation Information
6.3.2 Elabscience Biotechnology Inc. Description and Business Overview
6.3.3 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product Portfolio
6.3.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.4 Abbexa
6.4.1 Abbexa Corporation Information
6.4.2 Abbexa Description and Business Overview
6.4.3 Abbexa CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbexa CD30 (TNFRSF8) Protein Product Portfolio
6.4.5 Abbexa Recent Developments/Updates
6.5 MyBiosource, Inc.
6.5.1 MyBiosource, Inc. Corporation Information
6.5.2 MyBiosource, Inc. Description and Business Overview
6.5.3 MyBiosource, Inc. CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MyBiosource, Inc. CD30 (TNFRSF8) Protein Product Portfolio
6.5.5 MyBiosource, Inc. Recent Developments/Updates
6.6 OriGene Technologies, Inc.
6.6.1 OriGene Technologies, Inc. Corporation Information
6.6.2 OriGene Technologies, Inc. Description and Business Overview
6.6.3 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product Portfolio
6.6.5 OriGene Technologies, Inc. Recent Developments/Updates
6.7 Prospec-Tany Technogene Ltd.
6.6.1 Prospec-Tany Technogene Ltd. Corporation Information
6.6.2 Prospec-Tany Technogene Ltd. Description and Business Overview
6.6.3 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product Portfolio
6.7.5 Prospec-Tany Technogene Ltd. Recent Developments/Updates
6.8 KACTUS
6.8.1 KACTUS Corporation Information
6.8.2 KACTUS Description and Business Overview
6.8.3 KACTUS CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 KACTUS CD30 (TNFRSF8) Protein Product Portfolio
6.8.5 KACTUS Recent Developments/Updates
6.9 G&P Biosciences
6.9.1 G&P Biosciences Corporation Information
6.9.2 G&P Biosciences Description and Business Overview
6.9.3 G&P Biosciences CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 G&P Biosciences CD30 (TNFRSF8) Protein Product Portfolio
6.9.5 G&P Biosciences Recent Developments/Updates
6.10 ACROBiosystems
6.10.1 ACROBiosystems Corporation Information
6.10.2 ACROBiosystems Description and Business Overview
6.10.3 ACROBiosystems CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ACROBiosystems CD30 (TNFRSF8) Protein Product Portfolio
6.10.5 ACROBiosystems Recent Developments/Updates
6.11 Assay Genie
6.11.1 Assay Genie Corporation Information
6.11.2 Assay Genie CD30 (TNFRSF8) Protein Description and Business Overview
6.11.3 Assay Genie CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Assay Genie CD30 (TNFRSF8) Protein Product Portfolio
6.11.5 Assay Genie Recent Developments/Updates
6.12 ZellBio GmbH
6.12.1 ZellBio GmbH Corporation Information
6.12.2 ZellBio GmbH CD30 (TNFRSF8) Protein Description and Business Overview
6.12.3 ZellBio GmbH CD30 (TNFRSF8) Protein Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ZellBio GmbH CD30 (TNFRSF8) Protein Product Portfolio
6.12.5 ZellBio GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD30 (TNFRSF8) Protein Industry Chain Analysis
7.2 CD30 (TNFRSF8) Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD30 (TNFRSF8) Protein Production Mode & Process
7.4 CD30 (TNFRSF8) Protein Sales and Marketing
7.4.1 CD30 (TNFRSF8) Protein Sales Channels
7.4.2 CD30 (TNFRSF8) Protein Distributors
7.5 CD30 (TNFRSF8) Protein Customers
8 CD30 (TNFRSF8) Protein Market Dynamics
8.1 CD30 (TNFRSF8) Protein Industry Trends
8.2 CD30 (TNFRSF8) Protein Market Drivers
8.3 CD30 (TNFRSF8) Protein Market Challenges
8.4 CD30 (TNFRSF8) Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bio-Techne
Elabscience Biotechnology Inc.
Abbexa
MyBioSource
ProSpec-Tany TechnoGene Ltd
KACTUS
G&P Biosciences
ACROBiosystems
Assay Genie
ZellBio GmbH
Sino Biological Inc
OriGene Technologies, Inc.
List of Tables
    Table 1. Global CD30 (TNFRSF8) Protein Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global CD30 (TNFRSF8) Protein Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global CD30 (TNFRSF8) Protein Market Competitive Situation by Manufacturers in 2023
    Table 4. Global CD30 (TNFRSF8) Protein Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global CD30 (TNFRSF8) Protein Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global CD30 (TNFRSF8) Protein Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global CD30 (TNFRSF8) Protein Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market CD30 (TNFRSF8) Protein Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of CD30 (TNFRSF8) Protein, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of CD30 (TNFRSF8) Protein, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of CD30 (TNFRSF8) Protein, Product Type & Application
    Table 12. Global Key Manufacturers of CD30 (TNFRSF8) Protein, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global CD30 (TNFRSF8) Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD30 (TNFRSF8) Protein as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global CD30 (TNFRSF8) Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global CD30 (TNFRSF8) Protein Sales by Region (2019-2024) & (K Units)
    Table 18. Global CD30 (TNFRSF8) Protein Sales Market Share by Region (2019-2024)
    Table 19. Global CD30 (TNFRSF8) Protein Sales by Region (2025-2030) & (K Units)
    Table 20. Global CD30 (TNFRSF8) Protein Sales Market Share by Region (2025-2030)
    Table 21. Global CD30 (TNFRSF8) Protein Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global CD30 (TNFRSF8) Protein Revenue Market Share by Region (2019-2024)
    Table 23. Global CD30 (TNFRSF8) Protein Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global CD30 (TNFRSF8) Protein Revenue Market Share by Region (2025-2030)
    Table 25. North America CD30 (TNFRSF8) Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America CD30 (TNFRSF8) Protein Sales by Country (2019-2024) & (K Units)
    Table 27. North America CD30 (TNFRSF8) Protein Sales by Country (2025-2030) & (K Units)
    Table 28. North America CD30 (TNFRSF8) Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America CD30 (TNFRSF8) Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe CD30 (TNFRSF8) Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe CD30 (TNFRSF8) Protein Sales by Country (2019-2024) & (K Units)
    Table 32. Europe CD30 (TNFRSF8) Protein Sales by Country (2025-2030) & (K Units)
    Table 33. Europe CD30 (TNFRSF8) Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe CD30 (TNFRSF8) Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific CD30 (TNFRSF8) Protein Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific CD30 (TNFRSF8) Protein Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific CD30 (TNFRSF8) Protein Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific CD30 (TNFRSF8) Protein Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific CD30 (TNFRSF8) Protein Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America CD30 (TNFRSF8) Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America CD30 (TNFRSF8) Protein Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America CD30 (TNFRSF8) Protein Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America CD30 (TNFRSF8) Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America CD30 (TNFRSF8) Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa CD30 (TNFRSF8) Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa CD30 (TNFRSF8) Protein Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa CD30 (TNFRSF8) Protein Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa CD30 (TNFRSF8) Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa CD30 (TNFRSF8) Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global CD30 (TNFRSF8) Protein Sales (K Units) by Type (2019-2024)
    Table 51. Global CD30 (TNFRSF8) Protein Sales (K Units) by Type (2025-2030)
    Table 52. Global CD30 (TNFRSF8) Protein Sales Market Share by Type (2019-2024)
    Table 53. Global CD30 (TNFRSF8) Protein Sales Market Share by Type (2025-2030)
    Table 54. Global CD30 (TNFRSF8) Protein Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global CD30 (TNFRSF8) Protein Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global CD30 (TNFRSF8) Protein Revenue Market Share by Type (2019-2024)
    Table 57. Global CD30 (TNFRSF8) Protein Revenue Market Share by Type (2025-2030)
    Table 58. Global CD30 (TNFRSF8) Protein Price (US$/Unit) by Type (2019-2024)
    Table 59. Global CD30 (TNFRSF8) Protein Price (US$/Unit) by Type (2025-2030)
    Table 60. Global CD30 (TNFRSF8) Protein Sales (K Units) by Application (2019-2024)
    Table 61. Global CD30 (TNFRSF8) Protein Sales (K Units) by Application (2025-2030)
    Table 62. Global CD30 (TNFRSF8) Protein Sales Market Share by Application (2019-2024)
    Table 63. Global CD30 (TNFRSF8) Protein Sales Market Share by Application (2025-2030)
    Table 64. Global CD30 (TNFRSF8) Protein Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global CD30 (TNFRSF8) Protein Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global CD30 (TNFRSF8) Protein Revenue Market Share by Application (2019-2024)
    Table 67. Global CD30 (TNFRSF8) Protein Revenue Market Share by Application (2025-2030)
    Table 68. Global CD30 (TNFRSF8) Protein Price (US$/Unit) by Application (2019-2024)
    Table 69. Global CD30 (TNFRSF8) Protein Price (US$/Unit) by Application (2025-2030)
    Table 70. Sino Biological, Inc. Corporation Information
    Table 71. Sino Biological, Inc. Description and Business Overview
    Table 72. Sino Biological, Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Sino Biological, Inc. CD30 (TNFRSF8) Protein Product
    Table 74. Sino Biological, Inc. Recent Developments/Updates
    Table 75. Bio-Techne Corporation Information
    Table 76. Bio-Techne Description and Business Overview
    Table 77. Bio-Techne CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Bio-Techne CD30 (TNFRSF8) Protein Product
    Table 79. Bio-Techne Recent Developments/Updates
    Table 80. Elabscience Biotechnology Inc. Corporation Information
    Table 81. Elabscience Biotechnology Inc. Description and Business Overview
    Table 82. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product
    Table 84. Elabscience Biotechnology Inc. Recent Developments/Updates
    Table 85. Abbexa Corporation Information
    Table 86. Abbexa Description and Business Overview
    Table 87. Abbexa CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Abbexa CD30 (TNFRSF8) Protein Product
    Table 89. Abbexa Recent Developments/Updates
    Table 90. MyBiosource, Inc. Corporation Information
    Table 91. MyBiosource, Inc. Description and Business Overview
    Table 92. MyBiosource, Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. MyBiosource, Inc. CD30 (TNFRSF8) Protein Product
    Table 94. MyBiosource, Inc. Recent Developments/Updates
    Table 95. OriGene Technologies, Inc. Corporation Information
    Table 96. OriGene Technologies, Inc. Description and Business Overview
    Table 97. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product
    Table 99. OriGene Technologies, Inc. Recent Developments/Updates
    Table 100. Prospec-Tany Technogene Ltd. Corporation Information
    Table 101. Prospec-Tany Technogene Ltd. Description and Business Overview
    Table 102. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product
    Table 104. Prospec-Tany Technogene Ltd. Recent Developments/Updates
    Table 105. KACTUS Corporation Information
    Table 106. KACTUS Description and Business Overview
    Table 107. KACTUS CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. KACTUS CD30 (TNFRSF8) Protein Product
    Table 109. KACTUS Recent Developments/Updates
    Table 110. G&P Biosciences Corporation Information
    Table 111. G&P Biosciences Description and Business Overview
    Table 112. G&P Biosciences CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. G&P Biosciences CD30 (TNFRSF8) Protein Product
    Table 114. G&P Biosciences Recent Developments/Updates
    Table 115. ACROBiosystems Corporation Information
    Table 116. ACROBiosystems Description and Business Overview
    Table 117. ACROBiosystems CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. ACROBiosystems CD30 (TNFRSF8) Protein Product
    Table 119. ACROBiosystems Recent Developments/Updates
    Table 120. Assay Genie Corporation Information
    Table 121. Assay Genie Description and Business Overview
    Table 122. Assay Genie CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Assay Genie CD30 (TNFRSF8) Protein Product
    Table 124. Assay Genie Recent Developments/Updates
    Table 125. ZellBio GmbH Corporation Information
    Table 126. ZellBio GmbH Description and Business Overview
    Table 127. ZellBio GmbH CD30 (TNFRSF8) Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. ZellBio GmbH CD30 (TNFRSF8) Protein Product
    Table 129. ZellBio GmbH Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. CD30 (TNFRSF8) Protein Distributors List
    Table 133. CD30 (TNFRSF8) Protein Customers List
    Table 134. CD30 (TNFRSF8) Protein Market Trends
    Table 135. CD30 (TNFRSF8) Protein Market Drivers
    Table 136. CD30 (TNFRSF8) Protein Market Challenges
    Table 137. CD30 (TNFRSF8) Protein Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of CD30 (TNFRSF8) Protein
    Figure 2. Global CD30 (TNFRSF8) Protein Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global CD30 (TNFRSF8) Protein Market Share by Type in 2023 & 2030
    Figure 4. Purity : Greater Than 85% Product Picture
    Figure 5. Purity : Greater Than 90% Product Picture
    Figure 6. Purity : Greater Than 95% Product Picture
    Figure 7. Purity : Greater Than 97% Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global CD30 (TNFRSF8) Protein Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global CD30 (TNFRSF8) Protein Market Share by Application in 2023 & 2030
    Figure 11. SDS-PAGE
    Figure 12. ELISA
    Figure 13. Others
    Figure 14. Global CD30 (TNFRSF8) Protein Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global CD30 (TNFRSF8) Protein Market Size (2019-2030) & (US$ Million)
    Figure 16. Global CD30 (TNFRSF8) Protein Sales (2019-2030) & (K Units)
    Figure 17. Global CD30 (TNFRSF8) Protein Average Price (US$/Unit) & (2019-2030)
    Figure 18. CD30 (TNFRSF8) Protein Report Years Considered
    Figure 19. CD30 (TNFRSF8) Protein Sales Share by Manufacturers in 2023
    Figure 20. Global CD30 (TNFRSF8) Protein Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest CD30 (TNFRSF8) Protein Players: Market Share by Revenue in 2023
    Figure 22. CD30 (TNFRSF8) Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global CD30 (TNFRSF8) Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America CD30 (TNFRSF8) Protein Sales Market Share by Country (2019-2030)
    Figure 25. North America CD30 (TNFRSF8) Protein Revenue Market Share by Country (2019-2030)
    Figure 26. United States CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe CD30 (TNFRSF8) Protein Sales Market Share by Country (2019-2030)
    Figure 29. Europe CD30 (TNFRSF8) Protein Revenue Market Share by Country (2019-2030)
    Figure 30. Germany CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific CD30 (TNFRSF8) Protein Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific CD30 (TNFRSF8) Protein Revenue Market Share by Region (2019-2030)
    Figure 37. China CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America CD30 (TNFRSF8) Protein Sales Market Share by Country (2019-2030)
    Figure 45. Latin America CD30 (TNFRSF8) Protein Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa CD30 (TNFRSF8) Protein Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa CD30 (TNFRSF8) Protein Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE CD30 (TNFRSF8) Protein Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of CD30 (TNFRSF8) Protein by Type (2019-2030)
    Figure 55. Global Revenue Market Share of CD30 (TNFRSF8) Protein by Type (2019-2030)
    Figure 56. Global CD30 (TNFRSF8) Protein Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of CD30 (TNFRSF8) Protein by Application (2019-2030)
    Figure 58. Global Revenue Market Share of CD30 (TNFRSF8) Protein by Application (2019-2030)
    Figure 59. Global CD30 (TNFRSF8) Protein Price (US$/Unit) by Application (2019-2030)
    Figure 60. CD30 (TNFRSF8) Protein Value Chain
    Figure 61. CD30 (TNFRSF8) Protein Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global CD30 TNFRSF8 Antibody Market Research Report 2024
Global CD30 TNFRSF8 ELISA Kit Market Research Report 2024
Global TNFRSF1B Tumor Necrosis Factor Receptor Superfamily Member 1B ELISA Kit Market Research Report 2024
Global Tumor Necrosis Factor Antibody Market Research Report 2024
Global TNFSF9 Antibody Market Research Report 2024
Global Death Receptor 5 DR5 Protein Market Research Report 2024
Global CD40 Ligand CD40L Antibody Market Research Report 2024
CD320 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CD25 IL2R alpha Protein Market Research Report 2024
Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Research Report 2025
Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Research Report 2025
Global CD244 2B4 Protein Market Research Report 2024
Global Mouse TNF Market Research Report 2025
Global CD160 Protein Market Research Report 2024
Global Recombinant Human Tumor Necrosis Factor α ReceptorⅡ IgG Fc Fusion Protein for Injection Market Research Report 2024
Global Mouse TNF Reagent Market Research Report 2025
Global GMP Tumor Necrosis Factor Alpha Market Insights Forecast to 2030
Global Human FGFR3 Fibroblast growth factor receptor Market Research Report 2024
Global T Cell specific Surface Glycoprotein CD28 Antibody Market Research Report 2024
Global Immune Checkpoint Proteins Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions